Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
LifeVantage ( (LFVN) ) just unveiled an announcement.
On December 3, 2025, LifeVantage Corporation announced the resignations of two key executives. Julie Boyster, the Chief Marketing Officer, will leave her position on December 12, 2025, and Todd Thompson, the Chief Information and Innovation Officer, will depart on December 24, 2025, both to pursue other business opportunities.
The most recent analyst rating on (LFVN) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on LifeVantage stock, see the LFVN Stock Forecast page.
Spark’s Take on LFVN Stock
According to Spark, TipRanks’ AI Analyst, LFVN is a Neutral.
LifeVantage’s overall stock score reflects a mix of strong financial performance and attractive valuation, offset by bearish technical indicators and some operational challenges highlighted in the earnings call. The company’s strategic initiatives, particularly in the gut health market, provide a positive outlook, but maintaining operational efficiency and addressing cost pressures will be key to future success.
To see Spark’s full report on LFVN stock, click here.
More about LifeVantage
Average Trading Volume: 158,020
Technical Sentiment Signal: Sell
Current Market Cap: $83.83M
See more insights into LFVN stock on TipRanks’ Stock Analysis page.